Self-efficacy as a mediator between health technology readiness and health-related quality of life: A survey study with mediation analysis

• by Anna Vahteristo, Virpi Jylhä, Hanna Kuusisto

• June 19, 2026

Perianesthetic Complications in Genetic Mitochondrial Disease: A Review of Case Reports

• by Brittany M. Johnson, Simon C. Johnson

• July 7, 2026

Head-to-Head Trial in Relapsing MS

The phase 3 OVERLORD-MS trial compared 2 anti-CD20 therapies in previously untreated adults with newly diagnosed relapsing multiple sclerosis and recent inflammatory disease activity.

• by Kathryn Wighton

• July 7, 2026

• 6 min

Phoenix Children’s Joins First Controlled Clinical Trial of Genetic Therapy for Dravet Syndrome

The first controlled phase 3 trial of a genetic therapy for Dravet syndrome is now underway – with Phoenix Children's as one of 28 sites nationwide.

• by

• August 13, 2026

• 4 min